Maryland, 27 June 2024: The US Food and Drug Administration (FDA) published a much-anticipated draft guidance that recommends more diverse patient cohorts in clinical trials and is meant to improve the data the agency receives in support of premarket applications. It broadly desc......
View Details

Related News

• Critical medicines for cancer, diabetes set to get expensive as govt clears price hike, say sources (27-03-2025)

---

• DGFT proposes mandatory GST E-Invoices for pharma export benefits (27-03-2025)

---

• US FDA approves first treatment for rare genetic disorder Prader-Willi syndrome (27-03-2025)

---

• FDA approves GSK’s 'Blujepa' for uncomplicated UTIs (27-03-2025)

---

• Bengal drug control publishes helpline to report fake medicines (27-03-2025)

---

• Misleading ads: SC asks states UTs to set up grievance redressal mechanism (26-03-2025)

---

• WHO partners with regulators, experts to strengthen safety and access of medical devices (26-03-2025)

---

• PCI warns of tough action against inspectors who don't follow its guidelines during inspection (26-03-2025)

---

• Seizure of fake Human Albumin Vials rings alarm bells (26-03-2025)

---

• Pharmacy owner, three others held for illegal sale of intoxication drug (26-03-2025)

---